Literature DB >> 22743037

The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

Claire Vandergeeten1, Rémi Fromentin, Nicolas Chomont.   

Abstract

HIV persists in cellular and anatomical reservoirs during Highly Active Antiretroviral Therapy (HAART). In vitro studies as well as in vivo observations have identified cytokines as important factors regulating the immunological and virological mechanisms involved in HIV persistence. Immunosuppressive cytokines might contribute to the establishment of viral latency by dampening T cell activation and HIV production, thereby creating the necessary immuno-virological condition for the establishment of a pool of latently infected cells. Other cytokines that are involved in the maintenance of memory CD4(+) T cells promote the persistence of these cells during HAART. Conversely, proinflammatory cytokines may favor HIV persistence by exacerbating low levels of ongoing viral replication in lymphoid tissues even after prolonged therapy. The ability of several cytokines to interfere with the molecular mechanisms responsible for HIV latency makes them attractive candidates for therapeutic strategies aimed at reducing the pool of latently infected cells. In this article, we review the role of cytokines in HIV persistence during HAART and discuss their role as potential eradicating agents.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743037      PMCID: PMC3767481          DOI: 10.1016/j.cytogfr.2012.05.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  90 in total

Review 1.  Control of T cell viability.

Authors:  Philippa Marrack; John Kappler
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

2.  Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Authors:  L Al-Harthi; K A Roebuck; A Landay
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

3.  Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells.

Authors:  Y D Korin; J A Zack
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation.

Authors:  Ian McGowan; Julie Elliott; Marie Fuerst; Philip Taing; John Boscardin; Michael Poles; Peter Anton
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

5.  Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication.

Authors:  A Foli; M W Saville; M W Baseler; R Yarchoan
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

6.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Authors:  G Poli; A L Kinter; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells.

Authors:  Benedict Seddon; Peter Tomlinson; Rose Zamoyska
Journal:  Nat Immunol       Date:  2003-06-15       Impact factor: 25.606

9.  HIV-1 replication is controlled at the level of T cell activation and proviral integration.

Authors:  M Stevenson; T L Stanwick; M P Dempsey; C A Lamonica
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.

Authors:  T W Chun; D Engel; S B Mizell; L A Ehler; A S Fauci
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  27 in total

1.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.

Authors:  Erin T Larragoite; Racheal A Nell; Laura J Martins; Louis R Barrows; Vicente Planelles; Adam M Spivak
Journal:  Biochem Pharmacol       Date:  2021-11-18       Impact factor: 5.858

3.  Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.

Authors:  Michael J Corley; Alina P S Pang; Thomas A Rasmussen; Martin Tolstrup; Ole S Søgaard; Lishomwa C Ndhlovu
Journal:  AIDS       Date:  2021-11-15       Impact factor: 4.177

Review 4.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

5.  HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Authors:  Rebecca B Hasley; Changwan Hong; Wenqing Li; Travis Friesen; Yoriko Nakamura; Grace Y Kim; Jung-Hyun Park; Julie A Hixon; Scott Durum; Zonghui Hu; Michael C Sneller; Raphael Oguariri; Tomozumi Imamichi; H Clifford Lane; Marta Catalfamo
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

6.  Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.

Authors:  Steven A Yukl; Shahzada Khan; Tsui-Hua Chen; Martin Trapecar; Frank Wu; Guorui Xie; Sushama Telwatte; Daniel Fulop; Alexander R Pico; Gregory M Laird; Kristen D Ritter; Norman G Jones; Chuanyi M Lu; Robert F Siliciano; Nadia R Roan; Jeffrey M Milush; Ma Somsouk; Steven G Deeks; Peter W Hunt; Shomyseh Sanjabi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

7.  Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

Authors:  Sarah M Zaidan; Louise Leyre; Rémi Bunet; Etienne Larouche-Anctil; Isabelle Turcotte; Mohamed Sylla; Annie Chamberland; Carl Chartrand-Lefebvre; Petronela Ancuta; Jean-Pierre Routy; Jean-Guy Baril; Benoit Trottier; Paul MacPherson; Sylvie Trottier; Marianne Harris; Sharon Walmsley; Brian Conway; Alexander Wong; Réjean Thomas; Robert C Kaplan; Alan L Landay; Madeleine Durand; Nicolas Chomont; Cécile L Tremblay; Mohamed El-Far
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.731

Review 8.  HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs.

Authors:  Rémi Fromentin; Nicolas Chomont
Journal:  Semin Immunol       Date:  2020-11-30       Impact factor: 11.130

Review 9.  Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.

Authors:  Daniel A Donahue; Mark A Wainberg
Journal:  Retrovirology       Date:  2013-02-01       Impact factor: 4.602

Review 10.  A cure for AIDS: a matter of timing?

Authors:  Iart Luca Shytaj; Andrea Savarino
Journal:  Retrovirology       Date:  2013-11-22       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.